Equasens SA
PAR:EQS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
EV/OCF
Enterprise Value to Operating Cash Flow (EV/OCF) ratio compares a company`s total enterprise value to its operating cash flow. It shows how much investors are paying for each dollar of the company`s operating cash flow, including both equity and debt.
Enterprise Value to Operating Cash Flow (EV/OCF) ratio compares a company`s total enterprise value to its operating cash flow. It shows how much investors are paying for each dollar of the company`s operating cash flow, including both equity and debt.
Valuation Scenarios
If EV/OCF returns to its 3-Year Average (13.6), the stock would be worth €49.25 (22% upside from current price).
| Scenario | EV/OCF Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 11.1 | €40.25 |
0%
|
| 3-Year Average | 13.6 | €49.25 |
+22%
|
| 5-Year Average | 17.2 | €62.4 |
+55%
|
| Industry Average | 8.4 | €30.6 |
-24%
|
| Country Average | 9.9 | €36.07 |
-10%
|
Forward EV/OCF
Today’s price vs future operating cash flow
Peer Comparison
| Market Cap | EV/OCF | P/E | ||||
|---|---|---|---|---|---|---|
| FR |
|
Equasens SA
PAR:EQS
|
615.5m EUR | 11.1 | 16.7 | |
| US |
C
|
Cerner Corp
LSE:0R00
|
31.3B USD | 18.9 | 53.1 | |
| US |
|
Veeva Systems Inc
NYSE:VEEV
|
26.8B USD | 13.3 | 28.1 | |
| AU |
|
Pro Medicus Ltd
ASX:PME
|
14.7B AUD | 113.5 | 62.8 | |
| JP |
|
M3 Inc
TSE:2413
|
1T JPY | 13.4 | 20.2 | |
| SE |
|
Sectra AB
STO:SECT B
|
52.1B SEK | 63.6 | 97 | |
| US |
W
|
Waystar Holding Corp
NASDAQ:WAY
|
4.9B USD | 19.2 | 40.6 | |
| US |
|
Doximity Inc
NYSE:DOCS
|
4.5B USD | 11.4 | 18 | |
| US |
H
|
Heartflow Inc
NASDAQ:HTFL
|
2.8B USD | 0 | 0 | |
| CN |
|
Winning Health Technology Group Co Ltd
SZSE:300253
|
19B CNY | 37.5 | -61.5 | |
| US |
V
|
Vocera Communications Inc
F:V00
|
2.4B EUR | 61.3 | -328 |
Market Distribution
| Min | 0.3 |
| 30th Percentile | 6.5 |
| Median | 9.9 |
| 70th Percentile | 15.7 |
| Max | 2 301.8 |
Other Multiples
Equasens SA
Glance View
Equasens engages in the development of management software packages for drugstores. The company is headquartered in Villers-Les-Nancy, Grand Est. The company went IPO on 2000-10-20. The firm is engaged in the development and integration of management software packages for drugstores. The company offers all IT (Information Technology) and High-Tech fields related to Health and in specialized fields which are associated to it such as IT for pharmacies, solutions for e-Health, solutions for pharmaceutical industry, solutions for patients etc. The firm operates in four divisions that includes Europe Pharmacy Solutions Division including France Pharmacy Section and Belgium and Luxembourg Pharmacy Section, Solutions for sanitary and medico-social entities Division, e-Health Solutions Division including e-Laboratories section, e-Patients section and e-Connect section and Fintech Division.
